Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML'. Together they form a unique fingerprint.